NCX1022 is primarily studied for its potential therapeutic applications, particularly in the field of inflammation and pain management. It is known for its ability to inhibit cyclooxygenase-2 (COX-2) activity, which plays a key role in inflammatory processes. This makes it a candidate for treating conditions such as arthritis, where inflammation and pain are predominant symptoms. Additionally, its chemical structure allows it to release nitric oxide (NO), which can help improve blood flow and reduce gastrointestinal side effects often associated with traditional nonsteroidal anti-inflammatory drugs (NSAIDs). Research suggests it may offer a safer and more effective alternative for long-term use in managing chronic inflammatory diseases.